Condition: Skull Base Neoplasms · Cerebrospinal Fluid Leakage · Nasal; Hypertrophy, Mucous Membrane (Septum) · Sponsor: Indiana University
The purpose of this study is to specifically evaluate the effectiveness of PuraGel, a RADA16 polypeptide hydrogel, in expediting post-operative healing and re-mucosalization of the nasoseptal flap harvest site during endoscopic skull base surgery and the impact on patient and sinonasal morbidity.
This description comes directly from the study's public registry record.
Satyan Sreenath, MD · (317) 944-0457 · ssreenat@iu.edu
Always discuss trial participation with your own doctor first.
| Indiana University | Indianapolis, Indiana, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05898074